ReportGem ReportGem EN

普通外文研报

Etihad Etisalat Company SJSC "Good underlying Q1 growth, but limited..."

发布日期: 2026-05-18研究机构: UBS Equities公司 / 股票: 7020.SE报告页数: 19原文语言: 英语证据页码: 2

研报英文原文证据摘录

Etihad Etisalat Company SJSC "Good underlying Q1 growth, but limited..."

Etihad Etisalat Company SJSC UBS Research

Impact from lower device sales than expected

Mobily’s Q1 sales fell short of consensus estimates by 1%, an outcome we attribute to

weaker device sales not only for Mobily but across the broader market. Our analysis

indicates that device sales declined by approximately 60% y/y, primarily due to supply

chain disruptions. This section looks at the resulting effects on both revenues and gross

profit margins, and considers the potential impact should device sales recover over the

remainder of the year. Although management delivered EBITDA margins above

expectations this quarter, aided by a more favourable business mix, guidance for FY2026

EBITDA margins remains unchanged. This cautious stance likely reflects concerns that a

recovery in device sales could exert downward pressure on margins in the upcoming

quarters, especially as management has observed signs of improvement in device sales.

Had device sales maintained an underlying growth rate of around 2%, Q1 device sales

would have reached SAR285m, compared to the SAR118m actually recorded. This

shortfall equates to SAR167m in lost device sales, representing roughly two months of

sales either missed or deferred during the quarter. As a result, overall Q1 revenues were

around 3% below expectations in our view. With management signalling gradual

improvement, our base case assumes a further month of lost sales—SAR87m—

particularly in April, bringing total lost device sales over the past three months to

SAR250m. From Q2 onwards, we expect conditions to stabilise, with a recovery of

deferred sales likely in Q3 and Q4, predominantly in the final quarter.

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器